Search research articles
Contact Us
Filters
Showing results (21-30 of 107) with videos related to
Page
of 11
Sort By:
Cardiovascular Ultrasound
|
September 18, 2022
Myocardial contrast echocardiography assessment of perfusion abnormalities in hypertrophic cardiomyopathy
Paola Roldan, Sriram Ravi, James Hodovan, et al.
JAMA Cardiology
|
September 16, 2020
Initial Experience Prescribing Commercial Tafamidis, the Most Expensive Cardiac Medication in History
Ahmad Masri, Hongya Chen, Catherine Wong, et al.
Circulation. Cardiovascular Quality and Outcomes
|
October 26, 2018
Machine-Assisted Genotype Update System (MAGUS) for Inherited Cardiomyopathies
Nikolaos Papoutsidakis, Stephen B Heitner, Meghan C Mannello, et al.
BMJ Open
|
September 17, 2024
Qualitative interview study of patient-reported symptoms, impacts and treatment goals of patients with obstructive hypertrophic cardiomyopathy
Supriya Shore, Claire Ervin, Katherine Kosa, et al.
Clinical Pharmacokinetics
|
February 5, 2025
Effect of Hepatic Impairment or Renal Impairment on the Pharmacokinetics of Aficamten
Donghong Xu, Justin D Lutz, Punag Divanji, et al.
Clinical Pharmacokinetics
|
August 23, 2025
Correction: Effect of Hepatic Impairment or Renal Impairment on the Pharmacokinetics of Aficamten
Donghong Xu, Justin D Lutz, Punag Divanji, et al.
Expert Review of Clinical Pharmacology
|
July 4, 2019
Inotersen for the treatment of adults with polyneuropathy caused by hereditary transthyretin-mediated amyloidosis
Morie A Gertz, Morton Scheinberg, Márcia Waddington-Cruz, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
March 26, 2018
Standardized Goal-Directed Valsalva Maneuver for Assessment of Inducible Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy
Suwen Kumar, Grace Van Ness, Aron Bender, et al.
Journal of Cardiac Failure
|
December 8, 2023
EstimATTR: A Simplified, Machine-Learning-Based Tool to Predict the Risk of Wild-Type Transthyretin Amyloid Cardiomyopathy
Adam Castaño, Stephen B Heitner, Ahmad Masri, et al.
Clinical and Translational Science
|
April 9, 2025
Clinical Evaluation of the Effect of Aficamten on QT/QTc Interval in Healthy Participants
Neha Maharao, Donghong Xu, Tyrell J Simkins, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 107) with videos related to
Sort By:
Page
of 11
Cardiovascular Ultrasound
|
September 18, 2022
Myocardial contrast echocardiography assessment of perfusion abnormalities in hypertrophic cardiomyopathy
Paola Roldan, Sriram Ravi, James Hodovan, et al.
JAMA Cardiology
|
September 16, 2020
Initial Experience Prescribing Commercial Tafamidis, the Most Expensive Cardiac Medication in History
Ahmad Masri, Hongya Chen, Catherine Wong, et al.
Circulation. Cardiovascular Quality and Outcomes
|
October 26, 2018
Machine-Assisted Genotype Update System (MAGUS) for Inherited Cardiomyopathies
Nikolaos Papoutsidakis, Stephen B Heitner, Meghan C Mannello, et al.
BMJ Open
|
September 17, 2024
Qualitative interview study of patient-reported symptoms, impacts and treatment goals of patients with obstructive hypertrophic cardiomyopathy
Supriya Shore, Claire Ervin, Katherine Kosa, et al.
Clinical Pharmacokinetics
|
February 5, 2025
Effect of Hepatic Impairment or Renal Impairment on the Pharmacokinetics of Aficamten
Donghong Xu, Justin D Lutz, Punag Divanji, et al.
Clinical Pharmacokinetics
|
August 23, 2025
Correction: Effect of Hepatic Impairment or Renal Impairment on the Pharmacokinetics of Aficamten
Donghong Xu, Justin D Lutz, Punag Divanji, et al.
Expert Review of Clinical Pharmacology
|
July 4, 2019
Inotersen for the treatment of adults with polyneuropathy caused by hereditary transthyretin-mediated amyloidosis
Morie A Gertz, Morton Scheinberg, Márcia Waddington-Cruz, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography
|
March 26, 2018
Standardized Goal-Directed Valsalva Maneuver for Assessment of Inducible Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy
Suwen Kumar, Grace Van Ness, Aron Bender, et al.
Journal of Cardiac Failure
|
December 8, 2023
EstimATTR: A Simplified, Machine-Learning-Based Tool to Predict the Risk of Wild-Type Transthyretin Amyloid Cardiomyopathy
Adam Castaño, Stephen B Heitner, Ahmad Masri, et al.
Clinical and Translational Science
|
April 9, 2025
Clinical Evaluation of the Effect of Aficamten on QT/QTc Interval in Healthy Participants
Neha Maharao, Donghong Xu, Tyrell J Simkins, et al.
Page
of 11